APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etodolac

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Etodolac Market Outlook and Growth Opportunities 2026

23 December 2025195 pages

Choose your research edition.

Industry ResearchEtodolac Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Etodolac Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Etodolac Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etodolac Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Etodolac Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Etodolac market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Etodolac is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Etodolac is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Etodolac is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Etodolac market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Etodolac market include Teva, Taro Pharmaceuticals, Physicians Total Care, PD-Rx Pharmaceuticals, Nucare Pharmaceuticals, Genpharm Ulc, Eon Labs, Blenheim Pharmacal and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Etodolac market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Etodolac and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Etodolac sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Etodolac market size, projected growth trends, production technologies, key applications, and end-use industries.

Etodolac Segment by Company

Teva

Taro Pharmaceuticals

Physicians Total Care

PD-Rx Pharmaceuticals

Nucare Pharmaceuticals

Genpharm Ulc

Eon Labs

Blenheim Pharmacal

Apotex

Amneal Pharmaceuticals

Actavis Elizabeth

Etodolac Segment by Type

Tablets

Capsules

Etodolac Segment by Application

Mild to Moderate Pain

Rheumatoid Arthritis

Osteoarthritis

Others

Etodolac Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Etodolac status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Etodolac market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Etodolac significant trends, drivers, influence factors in global and regions.

6. To analyze Etodolac competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etodolac market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etodolac and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etodolac.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Etodolac market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Etodolac industry.

Chapter 3: Detailed analysis of Etodolac manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Etodolac in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Etodolac in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Etodolac Industry Trends Table 2. Etodolac Industry Drivers Table 3. Etodolac Industry Opportunities and Challenges Table 4. Etodolac Industry Restraints Table 5. Global Etodolac Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Etodolac Revenue Share by Company (2021-2026) Table 7. Global Etodolac Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Etodolac Sales Volume Share by Company (2021-2026) Table 9. Global Etodolac Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Etodolac Company Ranking, (2024-2026) & (USD Million) Table 11. Global Etodolac Key Company Manufacturing Base & Headquarters Table 12. Global Etodolac Company, Product Type & Application Table 13. Global Etodolac Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Etodolac by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Global Etodolac Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Etodolac Sales Volume by Type (2021-2026) & (k pcs) Table 21. Global Etodolac Sales Volume by Type (2027-2032) & (k pcs) Table 22. Global Etodolac Sales Volume Share by Type (2021-2026) Table 23. Global Etodolac Sales Volume Share by Type (2027-2032) Table 24. Global Etodolac Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Etodolac Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Etodolac Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Etodolac Sales Value Share by Type (2021-2026) Table 28. Global Etodolac Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Mild to Moderate Pain Table 30. Significant Companies of Rheumatoid Arthritis Table 31. Significant Companies of Osteoarthritis Table 32. Significant Companies of Others Table 33. Global Etodolac Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 34. Global Etodolac Sales Volume by Application (2021-2026) & (k pcs) Table 35. Global Etodolac Sales Volume by Application (2027-2032) & (k pcs) Table 36. Global Etodolac Sales Volume Share by Application (2021-2026) Table 37. Global Etodolac Sales Volume Share by Application (2027-2032) Table 38. Global Etodolac Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Etodolac Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Etodolac Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Etodolac Sales Value Share by Application (2021-2026) Table 42. Global Etodolac Sales Value Share by Application (2027-2032) Table 43. Global Etodolac Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Etodolac Sales by Region (2021-2026) & (k pcs) Table 45. Global Etodolac Sales Market Share by Region (2021-2026) Table 46. Global Etodolac Sales by Region (2027-2032) & (k pcs) Table 47. Global Etodolac Sales Market Share by Region (2027-2032) Table 48. Global Etodolac Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Etodolac Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Etodolac Sales Value Share by Region (2021-2026) Table 51. Global Etodolac Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Etodolac Sales Value Share by Region (2027-2032) Table 53. Global Etodolac Market Average Price (US$/pcs) by Region (2021-2026) Table 54. Global Etodolac Market Average Price (US$/pcs) by Region (2027-2032) Table 55. Global Etodolac Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 56. Global Etodolac Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Etodolac Sales by Country (2021-2026) & (k pcs) Table 58. Global Etodolac Sales Market Share by Country (2021-2026) Table 59. Global Etodolac Sales by Country (2027-2032) & (k pcs) Table 60. Global Etodolac Sales Market Share by Country (2027-2032) Table 61. Global Etodolac Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Etodolac Sales Value Market Share by Country (2021-2026) Table 63. Global Etodolac Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Etodolac Sales Value Market Share by Country (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 68. Teva Etodolac Product Portfolio Table 69. Teva Recent Development Table 70. Taro Pharmaceuticals Company Information Table 71. Taro Pharmaceuticals Business Overview Table 72. Taro Pharmaceuticals Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 73. Taro Pharmaceuticals Etodolac Product Portfolio Table 74. Taro Pharmaceuticals Recent Development Table 75. Physicians Total Care Company Information Table 76. Physicians Total Care Business Overview Table 77. Physicians Total Care Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 78. Physicians Total Care Etodolac Product Portfolio Table 79. Physicians Total Care Recent Development Table 80. PD-Rx Pharmaceuticals Company Information Table 81. PD-Rx Pharmaceuticals Business Overview Table 82. PD-Rx Pharmaceuticals Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 83. PD-Rx Pharmaceuticals Etodolac Product Portfolio Table 84. PD-Rx Pharmaceuticals Recent Development Table 85. Nucare Pharmaceuticals Company Information Table 86. Nucare Pharmaceuticals Business Overview Table 87. Nucare Pharmaceuticals Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 88. Nucare Pharmaceuticals Etodolac Product Portfolio Table 89. Nucare Pharmaceuticals Recent Development Table 90. Genpharm Ulc Company Information Table 91. Genpharm Ulc Business Overview Table 92. Genpharm Ulc Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 93. Genpharm Ulc Etodolac Product Portfolio Table 94. Genpharm Ulc Recent Development Table 95. Eon Labs Company Information Table 96. Eon Labs Business Overview Table 97. Eon Labs Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 98. Eon Labs Etodolac Product Portfolio Table 99. Eon Labs Recent Development Table 100. Blenheim Pharmacal Company Information Table 101. Blenheim Pharmacal Business Overview Table 102. Blenheim Pharmacal Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 103. Blenheim Pharmacal Etodolac Product Portfolio Table 104. Blenheim Pharmacal Recent Development Table 105. Apotex Company Information Table 106. Apotex Business Overview Table 107. Apotex Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 108. Apotex Etodolac Product Portfolio Table 109. Apotex Recent Development Table 110. Amneal Pharmaceuticals Company Information Table 111. Amneal Pharmaceuticals Business Overview Table 112. Amneal Pharmaceuticals Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 113. Amneal Pharmaceuticals Etodolac Product Portfolio Table 114. Amneal Pharmaceuticals Recent Development Table 115. Actavis Elizabeth Company Information Table 116. Actavis Elizabeth Business Overview Table 117. Actavis Elizabeth Etodolac Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 118. Actavis Elizabeth Etodolac Product Portfolio Table 119. Actavis Elizabeth Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Etodolac Distributors List Table 123. Etodolac Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Etodolac Product Image Figure 2. Global Etodolac Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etodolac Sales Value (2021-2032) & (US$ Million) Figure 4. Global Etodolac Sales (2021-2032) & (k pcs) Figure 5. Global Etodolac Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Etodolac Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Etodolac Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Etodolac Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Etodolac Sales Volume Share by Type (2021-2032) Figure 14. Global Etodolac Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Etodolac Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Etodolac Sales Value Share by Type (2021-2032) Figure 17. Mild to Moderate Pain Image Figure 18. Rheumatoid Arthritis Image Figure 19. Osteoarthritis Image Figure 20. Others Image Figure 21. Global Etodolac Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Etodolac Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Etodolac Sales Volume Share by Application (2021-2032) Figure 24. Global Etodolac Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Etodolac Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Etodolac Sales Value Share by Application (2021-2032) Figure 27. Global Etodolac Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 28. Global Etodolac Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Etodolac Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Etodolac Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Etodolac Sales Value (2021-2032) & (US$ Million) Figure 32. North America Etodolac Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Etodolac Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Etodolac Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Etodolac Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Etodolac Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Etodolac Sales Value (2021-2032) & (US$ Million) Figure 38. South America Etodolac Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Etodolac Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Etodolac Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Etodolac Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Etodolac Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Etodolac Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Etodolac Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Etodolac Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Mild to Moderate Pain
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Others
Companies covered
  • Teva
  • Taro Pharmaceuticals
  • Physicians Total Care
  • PD-Rx Pharmaceuticals
  • Nucare Pharmaceuticals
  • Genpharm Ulc
  • Eon Labs
  • Blenheim Pharmacal
  • Apotex
  • Amneal Pharmaceuticals
  • Actavis Elizabeth

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Etodolac Sales Value (2021-2032)
  4. 1.2.2 Global Etodolac Sales Volume (2021-2032)
  5. 1.2.3 Global Etodolac Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Etodolac Market Dynamics
  1. 2.1 Etodolac Industry Trends
  2. 2.2 Etodolac Industry Drivers
  3. 2.3 Etodolac Industry Opportunities and Challenges
  4. 2.4 Etodolac Industry Restraints
3 Etodolac Market by Company
  1. 3.1 Global Etodolac Company Revenue Ranking in 2025
  2. 3.2 Global Etodolac Revenue by Company (2021-2026)
  3. 3.3 Global Etodolac Sales Volume by Company (2021-2026)
  4. 3.4 Global Etodolac Average Price by Company (2021-2026)
  5. 3.5 Global Etodolac Company Ranking (2024-2026)
  6. 3.6 Global Etodolac Company Manufacturing Base and Headquarters
  7. 3.7 Global Etodolac Company Product Type and Application
  8. 3.8 Global Etodolac Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Etodolac Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Etodolac Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Etodolac Market by Type
  1. 4.1 Etodolac Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Etodolac Sales Volume by Type
  5. 4.2.1 Global Etodolac Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Etodolac Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Etodolac Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Etodolac Sales Value by Type
  9. 4.3.1 Global Etodolac Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Etodolac Sales Value by Type (2021-2032)
  11. 4.3.3 Global Etodolac Sales Value Share by Type (2021-2032)
5 Etodolac Market by Application
  1. 5.1 Etodolac Application Introduction
  2. 5.1.1 Mild to Moderate Pain
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Osteoarthritis
  5. 5.1.4 Others
  6. 5.2 Global Etodolac Sales Volume by Application
  7. 5.2.1 Global Etodolac Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Etodolac Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Etodolac Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Etodolac Sales Value by Application
  11. 5.3.1 Global Etodolac Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Etodolac Sales Value by Application (2021-2032)
  13. 5.3.3 Global Etodolac Sales Value Share by Application (2021-2032)
6 Etodolac Regional Sales and Value Analysis
  1. 6.1 Global Etodolac Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Etodolac Sales by Region (2021-2032)
  3. 6.2.1 Global Etodolac Sales by Region: 2021-2026
  4. 6.2.2 Global Etodolac Sales by Region (2027-2032)
  5. 6.3 Global Etodolac Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Etodolac Sales Value by Region (2021-2032)
  7. 6.4.1 Global Etodolac Sales Value by Region: 2021-2026
  8. 6.4.2 Global Etodolac Sales Value by Region (2027-2032)
  9. 6.5 Global Etodolac Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Etodolac Sales Value (2021-2032)
  12. 6.6.2 North America Etodolac Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Etodolac Sales Value (2021-2032)
  15. 6.7.2 Europe Etodolac Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Etodolac Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Etodolac Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Etodolac Sales Value (2021-2032)
  21. 6.9.2 South America Etodolac Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Etodolac Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Etodolac Sales Value Share by Country, 2025 VS 2032
7 Etodolac Country-level Sales and Value Analysis
  1. 7.1 Global Etodolac Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Etodolac Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Etodolac Sales by Country (2021-2032)
  4. 7.3.1 Global Etodolac Sales by Country (2021-2026)
  5. 7.3.2 Global Etodolac Sales by Country (2027-2032)
  6. 7.4 Global Etodolac Sales Value by Country (2021-2032)
  7. 7.4.1 Global Etodolac Sales Value by Country (2021-2026)
  8. 7.4.2 Global Etodolac Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Etodolac Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Etodolac Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Etodolac Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Etodolac Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Etodolac Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Etodolac Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Etodolac Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Etodolac Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Etodolac Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Etodolac Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Etodolac Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Etodolac Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Etodolac Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Etodolac Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Etodolac Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Etodolac Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Etodolac Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Etodolac Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Etodolac Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Etodolac Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Etodolac Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Etodolac Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Etodolac Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Etodolac Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Etodolac Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Etodolac Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Etodolac Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Etodolac Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Etodolac Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Etodolac Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Etodolac Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Etodolac Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Etodolac Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Etodolac Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Etodolac Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Etodolac Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Etodolac Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Etodolac Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Etodolac Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Etodolac Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Etodolac Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Etodolac Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Etodolac Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Etodolac Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Etodolac Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Etodolac Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Etodolac Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Etodolac Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Etodolac Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Etodolac Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Etodolac Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Etodolac Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Etodolac Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Etodolac Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Etodolac Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Etodolac Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Etodolac Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Etodolac Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Etodolac Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Etodolac Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Etodolac Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Etodolac Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Etodolac Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Etodolac Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Etodolac Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Etodolac Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Etodolac Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Etodolac Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Etodolac Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Etodolac Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Etodolac Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Etodolac Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Etodolac Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Etodolac Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Etodolac Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Etodolac Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Etodolac Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Etodolac Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Etodolac Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Etodolac Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Etodolac Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Etodolac Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Etodolac Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Etodolac Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Etodolac Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Etodolac Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Taro Pharmaceuticals
  8. 8.2.1 Taro Pharmaceuticals Company Information
  9. 8.2.2 Taro Pharmaceuticals Business Overview
  10. 8.2.3 Taro Pharmaceuticals Etodolac Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Taro Pharmaceuticals Etodolac Product Portfolio
  12. 8.2.5 Taro Pharmaceuticals Recent Developments
  13. 8.3 Physicians Total Care
  14. 8.3.1 Physicians Total Care Company Information
  15. 8.3.2 Physicians Total Care Business Overview
  16. 8.3.3 Physicians Total Care Etodolac Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Physicians Total Care Etodolac Product Portfolio
  18. 8.3.5 Physicians Total Care Recent Developments
  19. 8.4 PD-Rx Pharmaceuticals
  20. 8.4.1 PD-Rx Pharmaceuticals Company Information
  21. 8.4.2 PD-Rx Pharmaceuticals Business Overview
  22. 8.4.3 PD-Rx Pharmaceuticals Etodolac Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 PD-Rx Pharmaceuticals Etodolac Product Portfolio
  24. 8.4.5 PD-Rx Pharmaceuticals Recent Developments
  25. 8.5 Nucare Pharmaceuticals
  26. 8.5.1 Nucare Pharmaceuticals Company Information
  27. 8.5.2 Nucare Pharmaceuticals Business Overview
  28. 8.5.3 Nucare Pharmaceuticals Etodolac Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nucare Pharmaceuticals Etodolac Product Portfolio
  30. 8.5.5 Nucare Pharmaceuticals Recent Developments
  31. 8.6 Genpharm Ulc
  32. 8.6.1 Genpharm Ulc Company Information
  33. 8.6.2 Genpharm Ulc Business Overview
  34. 8.6.3 Genpharm Ulc Etodolac Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Genpharm Ulc Etodolac Product Portfolio
  36. 8.6.5 Genpharm Ulc Recent Developments
  37. 8.7 Eon Labs
  38. 8.7.1 Eon Labs Company Information
  39. 8.7.2 Eon Labs Business Overview
  40. 8.7.3 Eon Labs Etodolac Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Eon Labs Etodolac Product Portfolio
  42. 8.7.5 Eon Labs Recent Developments
  43. 8.8 Blenheim Pharmacal
  44. 8.8.1 Blenheim Pharmacal Company Information
  45. 8.8.2 Blenheim Pharmacal Business Overview
  46. 8.8.3 Blenheim Pharmacal Etodolac Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Blenheim Pharmacal Etodolac Product Portfolio
  48. 8.8.5 Blenheim Pharmacal Recent Developments
  49. 8.9 Apotex
  50. 8.9.1 Apotex Company Information
  51. 8.9.2 Apotex Business Overview
  52. 8.9.3 Apotex Etodolac Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Apotex Etodolac Product Portfolio
  54. 8.9.5 Apotex Recent Developments
  55. 8.10 Amneal Pharmaceuticals
  56. 8.10.1 Amneal Pharmaceuticals Company Information
  57. 8.10.2 Amneal Pharmaceuticals Business Overview
  58. 8.10.3 Amneal Pharmaceuticals Etodolac Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Amneal Pharmaceuticals Etodolac Product Portfolio
  60. 8.10.5 Amneal Pharmaceuticals Recent Developments
  61. 8.11 Actavis Elizabeth
  62. 8.11.1 Actavis Elizabeth Company Information
  63. 8.11.2 Actavis Elizabeth Business Overview
  64. 8.11.3 Actavis Elizabeth Etodolac Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Actavis Elizabeth Etodolac Product Portfolio
  66. 8.11.5 Actavis Elizabeth Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Etodolac Value Chain Analysis
  2. 9.1.1 Etodolac Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Etodolac Sales Mode & Process
  6. 9.2 Etodolac Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Etodolac Distributors
  9. 9.2.3 Etodolac Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst